Owning either of these large-cap biotech stocks has been a great way to get rich over the past decade. Shares of Celgene Corporation (NASDAQ: CELG) have quadrupled since 2007. Biogen Inc. (NASDAQ: BIIB) shareholders have seen their investment rise fivefold over the same time frame, before accounting for the Bioverativ spinoff earlier this year.